Balversa.com

Keyword Suggestion

Balversa

Balversa erdafitinib

Balversa drug

Balversa ema

Balversa package insert

Balversa cost

Balversa pi

Balversa janssen

Balversa hcp

Balversa side effects

Balversa prescribing information

Balversa fda

Balversa fda approval

Balversa dispensing pharmacy

Balversa ocular side effects

Balversa.com lookup results from whois.rrpproxy.net server:

Network

Owner

Abuse

Technical support

Domain Provider	Number Of Domains
godaddy.com	286730
namecheap.com	101387
networksolutions.com	69118
tucows.com	52617
publicdomainregistry.com	39120
whois.godaddy.com	32793
enomdomains.com	23825
namesilo.com	21429
domains.google.com	21384
cloudflare.com	20573
gmo.jp	18110
name.com	17601
fastdomain.com	14708
register.com	13495
net.cn	12481
ionos.com	12416
ovh.com	12416
gandi.net	12305
registrar.amazon.com	12111

Host Informations

Check all domain's dns records

See Web Sites Hosted on 104.18.38.149

Fetching Web Sites Hosted

Site Inspections

Port Scanner (IP: 104.18.38.149)

› Ftp: 21

› Ssh: 22

› Telnet: 23

› Smtp: 25

› Dns: 53

› Http: 80

› Pop3: 110

› Portmapper, rpcbind: 111

› Microsoft RPC services: 135

› Netbios: 139

› Imap: 143

› Ldap: 389

› Https: 443

› SMB directly over IP: 445

› Msa-outlook: 587

› IIS, NFS, or listener RFS remote_file_sharing: 1025

› Lotus notes: 1352

› Sql server: 1433

› Point-to-point tunnelling protocol: 1723

› My sql: 3306

› Remote desktop: 3389

› Session Initiation Protocol (SIP): 5060

› Virtual Network Computer display: 5900

› X Window server: 6001

› Webcache: 8080

Spam Check (IP: 104.18.38.149)

› Dnsbl-1.uceprotect.net:

› Dnsbl-2.uceprotect.net:

› Dnsbl-3.uceprotect.net:

› Dnsbl.dronebl.org:

› Dnsbl.sorbs.net:

› Spam.dnsbl.sorbs.net:

› Bl.spamcop.net:

› Recent.dnsbl.sorbs.net:

› All.spamrats.com:

› B.barracudacentral.org:

› Bl.blocklist.de:

› Bl.emailbasura.org:

› Bl.mailspike.org:

› Bl.spamcop.net:

› Cblplus.anti-spam.org.cn:

› Dnsbl.anticaptcha.net:

› Ip.v4bl.org:

› Fnrbl.fast.net:

› Dnsrbl.swinog.ch:

› Mail-abuse.blacklist.jippg.org:

› Singlebl.spamgrouper.com:

› Spam.abuse.ch:

› Spamsources.fabel.dk:

› Virbl.dnsbl.bit.nl:

› Cbl.abuseat.org:

› Dnsbl.justspam.org:

› Zen.spamhaus.org:

Email address with balversa.com

Found 0 emails of this domain

Recent Searched Sites

› Namegenerator.biz (3 seconds ago) / US

› Balversa.com (0 seconds ago) / US

› Teachers.net (21 seconds ago) / US

› Wr.ai (33 seconds ago) / US

› Herospeed.net (34 seconds ago) / GB

› Mywayristorante.com (13 seconds ago) / US

› Razorsedgecalgary.com (19 seconds ago) / CA

› Saaslawyer.org (8 seconds ago) / US

› Intraquotes.com (9 seconds ago) / US

› Yourcareerplace.com (5 seconds ago) / US

› Cbd-oil-premium-strength23052.blogzag.com (8 seconds ago) / US

› Intacctconnect.com (0 seconds ago) / US

› Vetalaw.com (1 seconds ago) / US

› Jobs-redefined.co (10 seconds ago) / DE

› Stevensshuttershoppeinc1.pagescene.com (2 mins ago) / US

› Blobit.org (54 seconds ago) / IT

› Bang-dream-cafe.jp (4 seconds ago) / JP

› C64-spielefuehrer.c64-wiki.de (11 seconds ago) / DE

› Yokohamacorp.co.jp (8 seconds ago) / JP

› Larawayfamilydentistry.com (42 seconds ago) / US

List of our tools

Emails by domain

Mobile Friendly Check

Page Speed Check

DNS Lookup

Ports Scan

Sites on host

Sitemap Generator

Websites Listing

We found Websites Listing below when search with balversa.com on Search Engine

BALVERSA (erdafitinib) – Ocular Toxicities: Overview, Screening …

BALVERSA™ (erdafitinib); the Canadian Product Monograph, October 25, 2019. FGFR signaling is thought to be involved in the maintenance, protection and repair of the retinal pigment epithelium for which inhibition could lead to CSR Erdafitinib also reacts with other tyrosine kinase receptors (RET, CSF1R, PDGFRA, FLT4, KIT, and VEGFR2) which may also contribute …

Janssenmedicalinformation.ca

Paying for BALVERSA® | Janssen CarePath

2022-04-01 · Janssen CarePath Savings Program for BALVERSA ®. If you are eligible, the Janssen CarePath Savings Program may provide instant savings on your private or commercial health insurance out-of-pocket costs for BALVERSA ®.Depending on your health insurance plan, savings may apply toward co-pay, co-insurance, or deductible.Eligible patients pay $5 per fill, …

Janssencarepath.com

Savings Program Overview - BALVERSA - Janssen CarePath

Information that may include your name, address, phone number, email address, and information related to your prescription medication insurance and treatment. This information is necessary to permit Janssen Biotech, Inc., the maker of BALVERSA®, and companies that work with Janssen Biotech, Inc., including our affiliates and our service

Janssencarepath.com

Balversa Prescription Form for VA Patients Phone: (877) 757-0667

Gender: Male Female Fax: (888) 899-0067 Phone: (877) 757-0667 VA Patient Information Prescriber Signature - Dispense as Written Prescriber Signature - Substitution Permissible

Balversahcp.com

Balversa (erdafitinib) dose, indications, adverse effects, interactions …

Adults. 8 mg PO once daily initially. After 14 to 21 days of treatment, increase the dose to 9 mg PO once daily if the serum phosphate level is less than 5.5 mg/dL and there are no ocular disorders or grade 2 or higher adverse reactions. Continue treatment until disease progression or unacceptable toxicity.

Pdr.net

Contact Us - Janssen EMEA

2022-04-01 · Thank you for your interest in learning more about Janssen. We care about your questions and concerns. Janssen EMEA operates in multiple countries. Choose a country below to find contact information relevant to your needs. ####filter-dropdown-global####

Janssen.com

Qiagen N.V. - QIAGEN launches first FDA-approved companion …

2019-04-12 · Novel therascreen® FGFR RGQ RT-PCR Kit will aid in identifying patients eligible for treatment with BALVERSA™ (erdafitinib), developed by Janssen Germantown, Maryland, and Hilden, Germany, April 12 2019 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the U.S. launch of its novel therascreen ® FGFR RGQ RT-PCR Kit …

Corporate.qiagen.com

Therapy Detail - The Jackson Laboratory

Email us at : [email protected]. Therapy Name: Erdafitinib Synonyms: Therapy Description : Balversa (erdafitinib) selectively inhibits FGFR1-4, resulting in decreased downstream signaling, and potentially leading to reduced growth of tumors with activated FGFR signaling (PMID: 28341788, PMID: 28965185). Balversa (erdafitinib) is FDA approved for use in patients with …

Ckb.jax.org

The potential of real-world data - Nature

2020-09-23 · We could use real-world data — say, a site’s electronic medical records — to see whether over the past 2 years a facility has been prescribing …

Nature.com

Products | Janssen Canada

Product Monograph (PDF) August 16, 2021. Patient Medication Information (PDF) August 16, 2021. Dear Doctor Letter (PDF) April 16, 2007. Dear Doctor Letter (PDF) October 13, 2004. Dear Doctor Letter (PDF) January 13, 2004. Dear Doctor Letter (PDF) June 25, 2002. Dear Doctor Letter (PDF) November 26, 2001.

Janssen.com

Unsubscribe | BALVERSA® (erdafitinib) HCP

2021-06-14 · Information about BALVERSA ® (erdafitinib) at this time.* Submit *You will continue to receive non-promotional emails such as information sent for purposes of patient safety or to facilitate our business relationship with you or as otherwise consistent with applicable law.

Cloud.e.janssen.com

Domains Expiration Date Updated

Site	Provider	Expiration Date
playav.in	godaddy.com	-1 Years, -232 Days
elitezap.com	namecheap.com	-2 Years, -62 Days
pismochamber.com	godaddy.com	-2 Years, -21 Days
championsdfw.com	wildwestdomains.com	264 Days
roadhousecinemas.com	godaddy.com	-1 Years, -194 Days
acharyaacademy.in	publicdomainregistry.com	-1 Years, -304 Days
gangz.io	ovh.com	-1 Years, -42 Days
hyipzoom.com	namecheap.com	-1 Years, -188 Days
yakamuuz.com	onlinenic.com	2 Years, 257 Days
ephrata.org	networksolutions.com	180 Days

Browser All